Popular on EntSun
- Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates - 400
- Stitt Entertainment Names Tristan Xavier Lead Stylist - 333
- ChargeOn Announces Conversational Payment Management Solution - 328
- Mecca to Mars: Earth's Escape? - 234
- Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism - 219
- Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 217
- Rehearsals Begin on 'The Call List' by Brian James Polak - 202
- Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not - 200
- Volant Announces Major Partnership with the STEM Racing Canada Program to CHAMPION YOUTH ENGINEERING - 190
- Big Panic Records Announces "African Sunshine" by Believe, Shirley Jones & Omasta - 185
Similar on EntSun
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Redefining Proactive Care: The Rise of the Hybrid Concierge Medical Model
- Calling all healthcare process experts: Share your ideas at #HSPI2027 in Orlando
- When the Coroner's Report Isn't Enough: Colorado Families Turn to Private Autopsy for Closure
- Independent Colbert Packaging Thrives Amid Industrywide Consolidation
- FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
- synseer Nominated for Best Startup in 2026 Prix Galien USA Awards Following Record Breaking Applicant Pool
- Crossroads4Hope Marks 25 Years Ensuring No One Faces Cancer Alone At its Inspiring Hope Gala
- KT Medical Staffing Addresses the Questions Families Forget to Ask Before Bringing Private Nursing Care Home
Recall of Glutathione, Myer's Cocktail, and Tri-Immune Boost
EntSun News/11102235
HOUSTON - EntSun -- Centric Compounding Issues Nationwide Recall of Glutathione, Myer's Cocktail, and Tri-Immune Boost Due to
Elevated Endotoxin Levels
Company Contact:
Lymar Crockett, CEO
833-777-6664 Option 11
FOR IMMEDIATE RELEASE – 9/9/2026 – Houston, Texas, Centric Compounding is voluntarily recalling 6 lots of Glutathione 200mg/mL, Myer's Cocktail, and Tri-Immune Boost injectable vials to the consumer level. The products have been found to be compounded with a Glutathione API containing elevated endotoxin levels.
Risk Statement: There is reasonable probability that injectable products with elevated endotoxin levels could cause significant medical events including fevesr, hypotension, inflammatory reactions, anaphylactic shock and death. Centric Compounding has received 9 reports of fever, chills, chest pain, nausea/vomiting, headache, and/or malaise.
The products are used to support immunity, fatigue, and general wellness and are packaged in 30mL multidose vials. The affected Glutathione, Myer's Cocktail, and Tri-Immune Boost lots include the following lot numbers and expiration dates:
More on EntSun News
Product Name Lot # Beyond Use Date
Glutathione 200mg/ml 30mL vial 062326:B 8/7/26
Glutathione 200mg/ml 30mL vial 070826:A 8/22/26
Glutathione 200mg/ml 30mL vial 072726:D 9/25/26
Myer's Cocktail 30mL vial 070226:D 8/16/26
Myer's Cocktail 30mL vial 072126:A 9/4/26
Tri-Immune Boost 30mL vial 071626:B 8/30/26
These products were distributed Nationwide to patients via home delivery and delivery to prescribers.
Centric Compounding is notifying its distributors and customers by email and is arranging for replacement of all recalled products. Consumers that have Glutathione, Myer's Cocktail, and Tri-Immune Boost which is being recalled should stop using and discard any affected vials.
Consumers with questions regarding this recall can contact Centric Compounding by phone at 833-777-6664 or info@centriccompounding.com on Monday through Friday from 9am to 5pm CST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
More on EntSun News
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Elevated Endotoxin Levels
Company Contact:
Lymar Crockett, CEO
833-777-6664 Option 11
FOR IMMEDIATE RELEASE – 9/9/2026 – Houston, Texas, Centric Compounding is voluntarily recalling 6 lots of Glutathione 200mg/mL, Myer's Cocktail, and Tri-Immune Boost injectable vials to the consumer level. The products have been found to be compounded with a Glutathione API containing elevated endotoxin levels.
Risk Statement: There is reasonable probability that injectable products with elevated endotoxin levels could cause significant medical events including fevesr, hypotension, inflammatory reactions, anaphylactic shock and death. Centric Compounding has received 9 reports of fever, chills, chest pain, nausea/vomiting, headache, and/or malaise.
The products are used to support immunity, fatigue, and general wellness and are packaged in 30mL multidose vials. The affected Glutathione, Myer's Cocktail, and Tri-Immune Boost lots include the following lot numbers and expiration dates:
More on EntSun News
- Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
- Cress Creeks Farm Opens Fall Corn Maze and Baby Lamb Hayride Experience in Ellijay, Georgia
- Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
- Hustle, Salsa & Bachata dance class at BigShots Roswell inside You42 Studio
- Pebble Photo Booths Brings Modern Photo Experiences to Vancouver, Washington
Product Name Lot # Beyond Use Date
Glutathione 200mg/ml 30mL vial 062326:B 8/7/26
Glutathione 200mg/ml 30mL vial 070826:A 8/22/26
Glutathione 200mg/ml 30mL vial 072726:D 9/25/26
Myer's Cocktail 30mL vial 070226:D 8/16/26
Myer's Cocktail 30mL vial 072126:A 9/4/26
Tri-Immune Boost 30mL vial 071626:B 8/30/26
These products were distributed Nationwide to patients via home delivery and delivery to prescribers.
Centric Compounding is notifying its distributors and customers by email and is arranging for replacement of all recalled products. Consumers that have Glutathione, Myer's Cocktail, and Tri-Immune Boost which is being recalled should stop using and discard any affected vials.
Consumers with questions regarding this recall can contact Centric Compounding by phone at 833-777-6664 or info@centriccompounding.com on Monday through Friday from 9am to 5pm CST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
More on EntSun News
- Chicago Creator Aaron Devere Unveils GOOBZ'D™, an Original Animated and Collectible Universe
- Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
- Emmy Nominee Sepideh Moafi And Peabody Award Winner Aasif Mandvi To Receive Cultural Impact Awards
- Originality Isn't Scarcity. Perspective Is
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
- Complete and submit the report Online: www.fda.gov/medwatch/report.htm
- Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Media Contact
info@centriccompounding.com
info@centriccompounding.com
Source: Centric Compounding
0 Comments
Latest on EntSun News
- Suits & Shoot Returns for 3rd Annual Noir Affair
- 'The Last Howl' Documentary Advocates for Conservation and Wildlife Preservation
- Venice FF 2026, Samantha Casella screens The Serpent's Caress
- 8th Edition of Filming Italy Venice Awards Cinema Talent
- STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
- Mandeville Pests May Pose Serious Health Risks for Your Family
- The Hot Sardines Return to Frederick for a Night of Vintage Jazz at the Weinberg Center
- Share your workplace safety solutions at 2027 Applied Ergonomics Conference
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
- May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
- Anti-Bullying Film The Karate Weirdo Secures Global Streaming Acquisition
- Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
- MainConcept Easy Video API Extends Full Transcoding to Arm and NETINT VPUs
- Metamora Events Brings New Interactive Event Experiences to Portland and Vancouver
- Disruptor Creations Options Untitled Feature Film Written by David Krumholtz and Johnny Markows
- The ABC's of Insurance Celebrates 600th TV Episode
- Cruxy shortlisted for two Private Equity Wire® US Awards 2026: Advisory Firm of the Year (Overall) & Value Creation Consulting Firm of the Year
- Revamping Fashion Sourcing: Speed and Flexibility Explained by Fashion Sourcing